A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors

This study is currently recruiting participants.

Study NCT00721669 Information provided by ImmunoGen, Inc.

First Received: July 22, 2008 Last Updated: August 4, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	January 2011
Estimated Primary Completion Date:	September 2010 (Final data collection date for primary outcome measure)